Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BHC
Bausch Health Companies Inc
stock NYSE

At Close
Jun 17, 2025 3:59:51 PM EDT
5.72USD-3.215%(-0.19)2,231,188
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 17, 2025 9:02:30 AM EDT
5.98USD+1.184%(+0.07)1,437
After-hours
Jun 17, 2025 4:55:30 PM EDT
5.98USD+4.545%(+0.26)28,361
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
04:21PM EST  Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes   PR Newswire
08:10AM EST  Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes   PR Newswire
Jan 21, 2022
09:43AM EST  Hearing Cramer Investing Club Buys Bausch Health   Benzinga
Jan 20, 2022
07:03AM EST  Yehia Hashad To Join Bausch + Lomb As EVP Of Research & Development And Chief Medical Officer   RTTNews
07:01AM EST  Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice   PR Newswire
Jan 18, 2022
07:55AM EST  Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes   Benzinga
07:50AM EST  Bausch Health Seeking To Refinance Existing Credit Agreement And Conditional Redemption Of Existing Notes   RTTNews
07:49AM EST  Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation   PR Newswire
Jan 14, 2022
08:07AM EST  The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake   Benzinga
Jan 13, 2022
04:28PM EST  Bausch Health Highlights Filing Of Registration Statement, Prelim. Prospectus For Proposed IPO   Benzinga
04:28PM EST  Bausch + Lomb Corporation Files Registration Statement and Preliminary   PR Newswire
Jan 11, 2022
07:01AM EST  Bausch Health Will Provide Business And Strategic Update At The 40th Annual   PR Newswire
Jan 5, 2022
07:01AM EST  BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE   PR Newswire
Jan 4, 2022
06:59AM EST  NEW SURVEY FROM BAUSCH + LOMB AND GLAUCOMA RESEARCH FOUNDATION REVEALS   PR Newswire
Dec 22, 2021
07:04AM EST  Bausch Health Highlights Publication Of RELISTOR In The Journal Of Emergency Medicine   Benzinga
07:01AM EST  RELISTOR(r) (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN THE JOURNAL OF   PR Newswire
Dec 6, 2021
07:02AM EST  Bausch Health Companies Announces APMA Grants Seal Of Approval For JUBLIA Topical Solution, 10%   Benzinga
07:01AM EST  Bausch Health : APMA Grants Seal Of Approval For JUBLIA Topical Solution, 10%   RTTNews
06:59AM EST  APMA Grants Seal of Approval for JUBLIA(r) (efinaconazole) Topical Solution, 10%   PR Newswire
Dec 3, 2021
07:00AM EST  Salix Brings Educational Resources on Constipation Into the Homes of Patients   PR Newswire
Nov 18, 2021
12:22PM EST  Watching Shares Of Bausch Health Companies; Co's Valeant Pharms Granted FDA Labeling Approval For Timoptic   Benzinga
Nov 15, 2021
06:59AM EST  Care Materials Recycled Through ONE By ONE And Biotrue(r) Eye Care Recycling Programs   PR Newswire
Nov 11, 2021
07:01AM EST  Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting(tm) 2021   PR Newswire
Nov 4, 2021
07:01AM EDT  Bausch Health Announces Participation In Upcoming Investor Conferences   PR Newswire
Nov 3, 2021
09:15AM EDT  RBC Capital Maintains Outperform on Bausch Health Companies, Lowers Price Target to $40   Benzinga
Nov 2, 2021
10:49AM EDT  UPDATE: Bausch Health Reaffirms FY21 Guidance: Adj. EBTIDA $3.35B-$3.5B, Sales $8.4B-$8.6B   Benzinga
10:48AM EDT  Bausch Health Companies Q3 GAAP EPS $0.52, Sales $2.11B Miss $2.66B Estimate; Reaffirms Guidance   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
10:21AM EDT  Bausch Health Q3 Profit Climbs   RTTNews
07:24AM EDT  Bausch Health Companies Q3 Net Income $188 Mln Up From $71 Mln Last Year   RTTNews
06:59AM EDT  Bausch Health Companies Inc. Announces Third-Quarter 2021 Results   PR Newswire
Nov 1, 2021
07:19AM EDT  Bausch + Lomb To Present Data During American Academy Of Ophthalmology & American Academy Of Optometry Meetings   RTTNews
07:01AM EDT  Bausch + Lomb Will Present Scientific Data and Analyses During the American   PR Newswire
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 28, 2021
09:28AM EDT  Clinicaltrials.gov Site Shows Bausch Health Study 'Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease' Not Yet Recruiting   Benzinga
07:14AM EDT  Bausch Health's Canada Unit Reports Its Dermatology Unit Launched New Topical Prescription Treatment For Acne Vulgaris ARAZLO, Available Across Canada   Benzinga
Oct 27, 2021
06:59AM EDT  Bausch + Lomb Launches Biotrue(r) Eye Care Recycling Program in Collaboration   PR Newswire
Oct 25, 2021
08:01AM EDT  New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients,   PR Newswire
07:01AM EDT  Salix Will Feature New Data At The American College Of Gastroenterology(r) 2021   PR Newswire
06:47AM EDT  Bausch + Lomb And Clearside Biomedical Announce FDA Approval Of XIPERE For Suprachoroidal Use For Treatment Of Macular Edema Associated With Uveitis   Benzinga
06:47AM EDT  Bausch + Lomb,Clearside Biomedical: FDA Approves XIPERE For Suprachoroidal Use For Macular Edema Associated With Uveitis   RTTNews
06:45AM EDT  (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis   PR Newswire
Oct 24, 2021
11:45AM EDT  The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More   Benzinga
Oct 21, 2021
12:11PM EDT  The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO   Benzinga
12:11PM EDT  Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma As Chief Financial Officer   Benzinga
07:12AM EDT  Bausch Health Says Tom Vadaketh Will Join Bausch Pharma As CFO   RTTNews
07:01AM EDT  Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief   PR Newswire
Oct 19, 2021
07:04AM EDT  Ortho Dermatologics To Present New Data At 2021 Fall Clinical Dermatology Conference   RTTNews
07:01AM EDT  Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology   PR Newswire
Oct 13, 2021
01:38PM EDT  Bausch Health Companies Sponsored Study Titled 'Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses' Posted To ClinicalTrials.gov, Study Not Yet Recruiting   Benzinga
Oct 6, 2021
07:01AM EDT  Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results   PR Newswire
Oct 4, 2021
07:05AM EDT  Clearside Biomedical, Inc.(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple presentations were given at the Retina Society 54th Annual Scientific Meeting which took place September 29 October 2, 2021 in Chicago, IL.   GlobeNewswire Inc
Oct 1, 2021
02:29PM EDT  Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates   Benzinga
Sep 30, 2021
07:58AM EDT  Bausch + Lomb: Second Phase 3 Trial Reaffirms Safety &   RTTNews
07:40AM EDT  Bausch Health Says Phase 3 Trial Of NOV03 Meets End Points In Dry Eye Disease   RTTNews
07:07AM EDT  Bausch + Lomb Unveils Significant Topline Results From II Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With MGD   RTTNews
07:00AM EDT  Bausch + Lomb Announces Statistically Significant Topline Results From The Second Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With Meibomian Gland Dysfunction; Co. Reports 'All Primary and Secondary Endpoints Were Achieved'   Benzinga
06:59AM EDT  Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction   PR Newswire
Sep 29, 2021
07:08AM EDT  Bausch Health Releases Annual Environmental, Social And Governance Report   RTTNews
Sep 21, 2021
11:06AM EDT  Canada-based healthcare company, Bausch Health Companies Inc. (BHC) is up 7% on the Tuesday market after dropping to the lowest in a month on Monday. The company has not released any stock-specific news to boost the stocks.   RTTNews
Sep 10, 2021
07:36PM EDT  Bausch Pays $300M For Diabetes Drug Lawsuit: Reuters   Benzinga
Sep 2, 2021
07:03AM EDT  Salix Pharma To Share RELISTOR Or Methylnaltrexone Bromide Data At PAINWeek 2021   RTTNews
07:01AM EDT  Salix Will Share RELISTOR(r) (Methylnaltrexone Bromide) Data At PAINWeek 2021   PR Newswire
Sep 1, 2021
07:01AM EDT  Bausch Health Announces Participation In Upcoming Investor Conferences   PR Newswire
Aug 13, 2021
10:05PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (Bausch or the Company) (NYSE: BHC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Aug 4, 2021
08:17AM EDT  Bausch Health,Canada, which is part of Bausch Health Companies Inc. (BHC, BHC.TO), and its dermatology division, said that Health Canada has approved the Notice of Compliance for ARAZLO or tazarotene lotion, 0.045%, for the topical treatment of acne vulgaris (common acne) in patients 10 years of age and older.   RTTNews
06:57AM EDT  Bausch Health : Health Canada Approves ARAZLO Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris   RTTNews
Aug 3, 2021
10:54AM EDT  Tuesday, Bausch Health Co. (BHC) is trading 8% lower in the early trading session after the company reported a wider loss in the second quarter. The company also announced a less impressive guidance for the year.   RTTNews
10:34AM EDT  Bausch Health Companies Inc. (BHC, BHC.TO) reported that its net loss for the second quarter of 2021 widened to $595 million from $326 million in the previous year, primarily due to the unfavorable change in operating results coupled with a decrease in the benefit from income taxes.   RTTNews
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
07:24AM EDT  Bausch Health Companies Reports Q2 Net Loss Of $595 Mln, Revenues Of $2.100 Bln   RTTNews
07:19AM EDT  Bausch Health Plans To Pursue IPO Of Solta Medical   RTTNews
07:01AM EDT  UPDATE: Bausch Health Cuts FY21 Sales Guidance From $8.6B-$8.8B To $8.4B-$8.6B vs $8.64B Estimate, Adj. EBITDA From $3.4B-$3.55B To $3.35B-$3.5B   Benzinga
07:00AM EDT  Bausch Health Companies Q2 GAAP Net Loss $595M, Adj. EBITDA $826M, Sales $2.10B Miss $2.12B Estimate; Cuts Guidance   Benzinga
06:59AM EDT  Bausch Health Companies Inc. Announces Second-Quarter 2021 Results   PR Newswire
06:57AM EDT  Bausch Health Announces Plans To Pursue An Initial Public Offering Of Solta   PR Newswire
06:57AM EDT  Bausch Health To Pursue IPO Of Its Solta Medical Unit   Benzinga
06:52AM EDT  Bausch Health To Reduce Debt By $350 Mln Through Redemption Of Outstanding Senior Notes   RTTNews
06:46AM EDT  Bausch Health To Reduce Debt By $350M Through Redemption Of Outstanding Senior Notes Using Cash On Hand And Cash Generated From Operations   Benzinga
06:45AM EDT  Bausch Health To Reduce Debt By $350 Million   PR Newswire
03:52AM EDT  Earnings Scheduled For August 3, 2021   Benzinga
Aug 2, 2021
10:53AM EDT  Earnings Outlook For Bausch Health Companies   Benzinga
07:03AM EDT  Bausch Health Completes Sale Of Amoun Pharma To Abu-Dhabi Based ADQ   RTTNews
07:01AM EDT  Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ   PR Newswire
Jul 29, 2021
07:01AM EDT  Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients   PR Newswire
Jul 22, 2021
07:01AM EDT  Salix Announces 2021 Gastrointestinal Health Scholars Program Winners   PR Newswire
Jul 19, 2021
07:01AM EDT  Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery   Benzinga
06:59AM EDT  Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery   PR Newswire
Jul 12, 2021
07:04AM EDT  Bausch + Lomb Launches Biotrue Hydration Boost Lubricant Eye Drops And Biotrue Micellar Eyelid Cleansing Wipes   RTTNews
07:00AM EDT  Bausch + Lomb Launches Biotrue(r) Hydration Boost Lubricant Eye Drops and   PR Newswire
Jul 7, 2021
07:07AM EDT  Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03   RTTNews
07:00AM EDT  Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane)   Benzinga
06:59AM EDT  Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03   PR Newswire
Jul 6, 2021
07:01AM EDT  Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results   PR Newswire
Jul 1, 2021
07:15AM EDT  Bausch Health To Reduce Debt By $150 Mln Through Redemption Of Outstanding Senior Notes, Using Cash Generated From Ops.   RTTNews
07:09AM EDT  Bausch Health To Reduce Debt By $150M Using Cash Generated From Operations   Benzinga
07:01AM EDT  Bausch Health To Reduce Debt By $150 Million Using Cash Generated From   PR Newswire
Jun 23, 2021
07:04AM EDT  Bausch + Lomb Expands Parameters For Bausch + Lomb ULTRA Multifocal For Astigmatism Contact Lenses   Benzinga
07:03AM EDT  Bausch + Lomb Unveils Expanded Parameters For Bausch + Lomb ULTRA Multifocal For Astigmatism Contact Lenses   RTTNews
07:01AM EDT  Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA(r) Multifocal for   PR Newswire
Jun 22, 2021
07:07AM EDT  Bausch Health Extends Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To June 22   RTTNews
07:01AM EDT  Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021   PR Newswire
Jun 21, 2021
07:02AM EDT  Bausch Health Announces Robert Hale Resigns From Board Of Directors   RTTNews
07:01AM EDT  Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors   PR Newswire
Jun 8, 2021
07:01AM EDT  Bausch + Lomb And Lochan Agree To Develop Next-Generation Of EyeTELLIGENCE Clinical Decision Support Software   RTTNews
06:59AM EDT  Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of   PR Newswire
Jun 7, 2021
06:47PM EDT  Bausch Health Announces Early Tender Results And Early Settlement Date For Cash   PR Newswire
Jun 2, 2021
07:25AM EDT  Bausch Health And Clearside Biomedical Announce FDA Filing Acceptance For XIPERE; Assigns PDUFA Action Date Of Oct 30   RTTNews
07:00AM EDT  Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE   Benzinga
06:59AM EDT  Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For   PR Newswire
Jun 1, 2021
06:59AM EDT  Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract   PR Newswire
May 27, 2021
08:24AM EDT  The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs   Benzinga
07:17AM EDT  Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations   RTTNews
07:01AM EDT  Bausch Health To Reduce Debt By $100 Million Using Cash Generated From   PR Newswire
May 25, 2021
07:01AM EDT  Bausch Health Announces Participation At The Jefferies Healthcare Conference   PR Newswire
May 24, 2021
05:30PM EDT  Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes   PR Newswire
08:26AM EDT  Bausch Health Launches Offering Of $1.6 Bln Of New Senior Secured Notes Due 2028   RTTNews
08:24AM EDT  Bausch Health Commences Cash Tender Offer For 7% Senior Secured Notes Due 2024   RTTNews
08:21AM EDT  Bausch Health Commences Cash Tender Offer For Any And All Of Its 7.00% Senior   PR Newswire
08:20AM EDT  Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And   PR Newswire
May 17, 2021
07:01AM EDT  Salix Will Feature New Data At Digestive Disease Week(r) 2021   PR Newswire
May 14, 2021
05:01PM EDT  Icahn 13F Shows Raised Stake In Bausch Health   Benzinga
May 11, 2021
07:00AM EDT  Bausch + Lomb Highlights National Eye Institute Data Showing AREDS2 Nutrient Formula 'Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression'   Benzinga
06:59AM EDT  Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression   PR Newswire
May 6, 2021
07:00AM EDT  Bausch Health Announces Participation In Upcoming Investor Conferences   PR Newswire
May 4, 2021
10:33AM EDT  Bausch Health Companies Inc. (BHC) shares are declining on Tuesday morning trade after the company reported a wider net loss for the first quarter.   RTTNews
09:14AM EDT  Bausch Health Reports Wider Q1 Loss, Hit By Impairment Charges On Ortho Dermatologics   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
07:24AM EDT  Bausch Health Companies Q1 Net Loss $610 Mln Vs. Net Loss $152 Mln Last Year   RTTNews
07:07AM EDT  Bausch Health Reaffirms FY21 Guidance: Adj. EBITDA $3.4B-$3.55B, Sales $8.6B-$8.8B vs $8.66B Estimate   Benzinga
07:06AM EDT  Bausch Health Companies Q1 Adj. Net Income $370M vs $316M In Same Qtr. Last Year, Adj. EBITDA $852M vs $813M Year Over Year, Sales $2.03B Miss $2.06B Estimate   Benzinga
07:00AM EDT  Bausch Health Companies Inc. Announces First-Quarter 2021 Results   PR Newswire
May 3, 2021
07:15AM EDT  Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations   RTTNews
07:05AM EDT  Clearside Biomedical Announces Resubmission of New Drug   GlobeNewswire Inc
07:01AM EDT  Bausch Health To Reduce Debt By $100 Million Using Cash Generated From   PR Newswire
Apr 29, 2021
12:36PM EDT  Bausch Health Exploring Potential Divestiture Of Eye Care Units: Bloomberg   Benzinga
07:30AM EDT  Bausch + Lomb To Present New Scientific Data And Analyses On Products And Pipeline Programs   RTTNews
06:59AM EDT  Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting   PR Newswire
Apr 28, 2021
03:34PM EDT  Bloomberg Reports Bausch Health Is Said To Explore A Potential Eye-Care Unit Sale   Benzinga
03:18PM EDT  Bausch Health Companies Option Alert: Fri $30.5 Calls at the Ask: 300 @ $3.5 vs 1364 OI; Earnings 5/4 Before Open Ref=$34.0   Benzinga
07:01AM EDT  Bausch Health Announces 2021 Annual Meeting of Shareholder Results   PR Newswire
Apr 27, 2021
07:01AM EDT  Bausch Health Issues Form 8-K for 2021 Annual Meeting of Shareholders   PR Newswire
Apr 22, 2021
07:05AM EDT  Bausch Health Companies' Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris   Benzinga
06:59AM EDT  Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris   PR Newswire
Apr 21, 2021
07:00AM EDT  Bausch Health's Ortho Dermatologics To Present At 2021 American Academy Of Dermatology Annual Meeting Apr. 23-25   Benzinga
06:59AM EDT  Ortho Dermatologics to Present New Data at the 2021 American Academy of   PR Newswire
Apr 16, 2021
07:02AM EDT  Bausch Health Announces VYZULTA 0.024%, Is Now Approved In Brazil   Benzinga
07:01AM EDT  Bausch Health Announces VYZULTA(r) (latanoprostene bunod ophthalmic solution),   PR Newswire
01:53AM EDT  Bausch Health Companies Inc. (BHC), Bausch + Lomb, and Nicox announced VYZULTA, 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency. It is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The approval of VYZULTA in Brazil marks its tenth regulatory approval.   RTTNews
01:39AM EDT  Bausch Health And Nicox: VYZULTA 0.024% Gets Approval From Brazilian Health Regulatory Agency   RTTNews
Apr 15, 2021
08:49AM EDT  Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic   PR Newswire
Apr 13, 2021
08:04AM EDT  Bausch + Lomb, eye health business of Bausch Health Companies Inc. (BHC, BHC.TO), and Novaliq GmbH said that all primary and secondary endpoints were achieved in the first phase 3 trial of NOV03 or perfluorohexyloctane in dry eye disease associated with meibomian gland dysfunction.   RTTNews
07:05AM EDT  Bausch + Lomb Says Topline Results From Phase 3 Trial Of NOV03 Meets Primary And Secondary Endpoints   RTTNews
06:59AM EDT  Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With Meibomian Gland Dysfunction; All Primary And Secondary Endpoints Were Achieved   Benzinga
06:58AM EDT  First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction   PR Newswire
Apr 9, 2021
07:01AM EDT  Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results   PR Newswire
Apr 8, 2021
07:07AM EDT  Bausch Health Reports U.S. Launch Of Novel Daily Over-the-counter Probiotic Supplement, ENVIVE   RTTNews
07:03AM EDT  Bausch Health Launches ENVIVE Daily Probiotic   Benzinga
07:01AM EDT  Bausch Health Launches ENVIVE(tm) Daily Probiotic Supplement   PR Newswire
Apr 7, 2021
07:34AM EDT  Bausch + Lomb: FDA Approves ClearVisc Dispersive Ophthalmic Viscosurgical Device   RTTNews
07:31AM EDT  Bausch + Lomb Receives FDA Approval For ClearVisc Dispersive Ophthalmic Viscosurgical Device   Benzinga
07:31AM EDT  FDA Approves Bausch + Lomb ClearVisc(tm) Dispersive Ophthalmic Viscosurgical   PR Newswire
07:12AM EDT  Bausch Health Companies Plans To Reduce Debt By $100 Mln Through Redemption Of Senior Secured Notes   RTTNews
07:06AM EDT  Bausch Health To Reduce Debt By $100M Using Cash Generated From Operations   Benzinga
07:01AM EDT  Bausch Health To Reduce Debt By $100 Million Using Cash Generated From   PR Newswire
Mar 31, 2021
08:18AM EDT  Bausch Health Companies Inc. (BHC, BHC.TO) said the company and certain of its affiliates have entered into a definitive agreement to sell all of their equity interests in Amoun Pharmaceutical Company S.A.E. to Abu-Dhabi based ADQ, for total gross consideration of approximately $740 million.   RTTNews
08:10AM EDT  Bausch Health Companies, Affiliates To Sell All Equity Interests In Amoun Pharmaceutical To Abu-Dhabi Based ADQ   RTTNews
08:08AM EDT  Bausch Health Agrees To Sell Amoun Pharma For Total Gross Consideration Of About $740 Mln   RTTNews
08:07AM EDT  Bausch Health To Sell Amoun Pharmaceuticals For $740M   Benzinga
08:01AM EDT  Bausch Health Agrees To Sell Amoun Pharmaceuticals   PR Newswire
Mar 30, 2021
09:04AM EDT  Website Designed To Provide Nurse Practitioners and Physician Assistants With Relevant Information for Treating IBS-D and HE   PR Newswire
Mar 24, 2021
11:43AM EDT  Why Did BofA Downgrade Bausch Health?   Benzinga
10:08AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2021   Benzinga
07:49AM EDT  B of A Securities Downgrades Bausch Health Companies to Underperform, Announces $27 Price Target   Benzinga
Mar 16, 2021
07:03AM EDT  HC Wainwright & Co. Maintains Buy on Bausch Health Companies, Raises Price Target to $55   Benzinga
Mar 11, 2021
08:19AM EST  The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena   Benzinga
07:28AM EST  Bausch Health Promotes Sam Eldessouky To Succeed Paul   RTTNews
07:15AM EST  Bausch Health Announces Sam Eldessouky Will Succeed Paul S. Herendeen as Chief Financial Officer; Herendeen Will Remain at Bausch Health as Advisor to the Chairman and CEO   Benzinga
07:08AM EST  Bausch Health Says Sam Eldessouky To Succeed Paul Herendeen As CFO, Effective June 1, 2021   RTTNews
07:08AM EST  Bausch Health Companies Names Sam Eldessouky To Succeed Paul Herendeen As CFO   RTTNews
07:01AM EST  Bausch Health Announces CFO Succession Plan   PR Newswire
Mar 10, 2021
09:40AM EST  Return On Capital Employed Overview: Bausch Health Companies   Benzinga
07:26AM EST  The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link   Benzinga
Mar 9, 2021
12:57PM EST  Pete Najarian Sees Unusual Option Activity In Tesla And Bausch Health   Benzinga
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
09:16AM EST  Bausch Health Provides Pipeline Update For The Barclays Global Healthcare Conference Today At 2:25 p.m. ET   Benzinga
07:01AM EST  Bausch Health Publishes Pipeline Update For The Barclays Global Healthcare   PR Newswire
Mar 8, 2021
07:00AM EST  Bausch Health Companies Announces the US Launch of its Clear + Brilliant Touch Laser   Benzinga
06:59AM EST  Solta Medical Announces U.S. Launch Of The Clear + Brilliant Touch Laser   RTTNews
06:58AM EST  Solta Medical Announces the U.S. Launch of The Clear + Brilliant(r) Touch Laser   PR Newswire
Mar 4, 2021
08:12AM EST  The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company   Benzinga
Feb 26, 2021
08:34AM EST  Morgan Stanley Maintains Equal-Weight on Bausch Health Companies, Raises Price Target to $35   Benzinga
07:13AM EST  Bausch Health To Reduce Debt By $100M Using Cash Generated From Operations   Benzinga
07:01AM EST  Bausch Health To Reduce Debt By $100 Million Using Cash Generated From   PR Newswire
Feb 25, 2021
07:40AM EST  A Look Into Bausch Health's Debt   Benzinga
Feb 24, 2021
01:50PM EST  Bausch Health Adds 2 Directors Chosen By Carl Icahn: What Investors Need To Know   Benzinga
07:48AM EST  Recap: Bausch Health Q4 Earnings   Benzinga
07:44AM EST  Bausch Health Q4 Loss Narrows; To Add Two Designees To   RTTNews
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
07:02AM EST  Bausch Health Companies Q4 GAAP Net Loss $153 Mln; Adjusted EBITDA $911 Mln   RTTNews
07:01AM EST  Bausch Health Sees FY21 Sales $8.6B-$8.8B vs $8.5B Estimate, Adj. EBITDA $3.4B-$3.55B   Benzinga
07:00AM EST  Bausch Health Companies Q4 Adj. EBITDA $911M, Sales $2.21B Beat $2.17B Estimate   Benzinga
07:00AM EST  Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020   PR Newswire
06:47AM EST  Bausch Health To Add Two Designees To Board From Carl Icahn And Affiliated Entities   RTTNews
06:46AM EST  Bausch Health Will Expand Board Of Directors And Add Two Designees From The Icahn Group   Benzinga
06:45AM EST  Bausch Health Announces Agreement With Carl C. Icahn   PR Newswire
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 23, 2021
07:01AM EST  Bausch + Lomb Launches Alaway(r) Preservative Free Antihistamine Eye Drops   PR Newswire
Feb 22, 2021
07:16AM EST  Bausch Health to Reduce Debt by $100M Using Cash From Operations   Benzinga
07:01AM EST  Bausch Health To Reduce Debt By $100 Million Using Cash Generated From   PR Newswire
Feb 18, 2021
08:31AM EST  Salix Announces 2021 Gastrointestinal Health Scholars Program   PR Newswire
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
Feb 17, 2021
02:44PM EST  Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios   Benzinga
10:12AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021   Benzinga
08:36AM EST  10 Biggest Price Target Changes For Wednesday   Benzinga
07:19AM EST  RBC Capital Upgrades Bausch Health Cos to Outperform, Raises Price Target to $42   Benzinga
Feb 16, 2021
03:24PM EST  $1,000, 5 Years Later: Valeant's Wild Ride To Bausch Health   Benzinga
07:02AM EST  Bausch Health Announces Participation In Upcoming Investor Conferences   PR Newswire
Feb 12, 2021
02:50PM EST  Why Bausch Health's Stock Is Trading Higher Today   Benzinga
Feb 11, 2021
09:27PM EST  Bausch Health Responds To Schedule 13D Filing From Icahn Capital LP   PR Newswire
05:12PM EST  CORRECTION: Icahn Partners Reports 7.83% Active Stake In Bausch Health Companies   Benzinga
05:12PM EST  Icahn Partners Reports 7.83% Active Stake In Bausch Health Companies   Benzinga
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 9, 2021
07:31AM EST  Bausch Health Companies Says VYZULTA Receives Regulatory Approval From Ministry Of Food And Drug Safety In South Korea   RTTNews
07:03AM EST  Bausch Health Announces VYZULTA, 0.024%, Is Now Approved In South Korea   Benzinga
07:01AM EST  Bausch Health Announces VYZULTA(r) (latanoprostene bunod ophthalmic solution),   PR Newswire
Feb 8, 2021
07:05AM EST  - Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders -   GlobeNewswire Inc
Feb 2, 2021
07:01AM EST  Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program   PR Newswire
Feb 1, 2021
07:01AM EST  Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise   PR Newswire
Jan 27, 2021
07:01AM EST  Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020   PR Newswire
Jan 21, 2021
07:02AM EST  South Korea's MFDS Approves LUMIFY Eye Drops   Benzinga
Jan 20, 2021
07:03AM EST  Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium   Benzinga
07:02AM EST  Bausch + Lomb To Present Scientific Data On Bausch + Lomb INFUSE Silicone Hydrogel Daily Disposable Contact Lenses   RTTNews
07:00AM EST  Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium   PR Newswire
Jan 19, 2021
07:10AM EST  Bausch + Lomb Completes Enrollment Of First Phase 3 Study For Perfluorohexyloctane   RTTNews
07:09AM EST  Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03   Benzinga
Jan 13, 2021
11:36AM EST  Bausch Health Companies Shares See Volume; Traders Circulate Truist Note   Benzinga
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 12, 2021
04:18PM EST  Bausch Health Expects To Exceed FY20 Target For $1B In Cash Generated From Operations   Benzinga
04:18PM EST  Bausch Health Sees FY20 Sales Above High End Of $7.8B-$8B Range vs $7.93B Estimate   Benzinga
04:17PM EST  Bausch Health Sees Q4 Sales Greater Than $2.2B vs $2.12B Estimate   Benzinga
04:16PM EST  Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020   PR Newswire
Jan 6, 2021
07:01AM EST  Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare   PR Newswire
Dec 30, 2020
07:23AM EST  Bausch Health's Dexaven Gets New Indication In Poland To   RTTNews
07:08AM EST  Bausch Health's DEXAVEN Receives New Indication In Poland To Treat Patients With SARS-CoV-2   RTTNews
07:02AM EST  Bausch Health Reports Its DEXAVEN Received New Indication In Poland To Treat Patients With SARS-CoV-2   Benzinga
07:01AM EST  Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In   PR Newswire
Dec 29, 2020
07:15AM EST  Bausch Health Companies Inc. (BHC, BHC.TO) said Tuesday that it will pay down an additional $275 million of its senior secured term loans on December 31, 2020, using the cash on hand and cash generated from operations. Following this repayment, the company will have no debt maturities or mandatory amortization payments until 2024.   RTTNews
07:05AM EST  Bausch Health To Pay Down Additional $275M Of Senior Secured Term Loans Using Cash On Hand And Cash from Operations   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC